Recent evidence suggests that an area in the dorsal medial prefrontal cortex (dorsal nexus) shows dramatic increases in connectivity across a network of brain regions in depressed patients during the resting state; 1 this increase in connectivity is suggested to represent hotwiring of areas involved in disparate cognitive and emotional functions. [1] [2] [3] Sheline et al. 1 concluded that antidepressant action may involve normalisation of the elevated resting state functional connectivity seen in depressed patients. However, the effects of conventional pharmacotherapy for depression on this resting state functional connectivity is not known and the effects of antidepressant treatment in depressed patients may be confounded by change in symptoms following treatment.
To test the hypothesis that decreasing the activity of the 'dorsal nexus' might be a potential therapeutic target for depression, we examined the effects of an SSRI (citalopram, 20 mg daily) given for 7 days to 30 healthy (mean age 25 and range±5 years) volunteers, matched for age and gender, with no previous psychiatric history, in a double-blind placebo-controlled design. Resting state data were available for 12 healthy volunteers in the citalopram group and 15 healthy volunteers in the placebo group. We used resting-state functional magnetic resonance imaging and seed-based connectivity analysis, in which we selected the right and left dorsal medial prefrontal cortex from Sheline et al.
1 study as seed regions (see Supplementary Material for details). Such an approach allowed us to examine changes in connectivity early on in treatment and in the absence of changes in subjective state.
As expected, citalopram did not affect mood or subjective state. 4 However, there was reduced connectivity between the left dorsal nexus seed region and the left hippocampus following SSRI administration ( Figure 1 ).
These data indicate that a standard antidepressant medication can modulate resting state functional connectivity between the dorsal nexus region of the brain and parts of the default mode network in healthy, never depressed volunteers and suggest that antidepressant medication may work by rebalancing cortical control in depression.
Although we found functional connectivity between the dorsomedial prefrontal cortex regions in the placebo group and areas such as the dorsal frontal gyrus (BA8, BA9), and also the anterior and subgenual cingulate cortices (BA32, BA25) on the left and right as expected, we only found connectivity with the hippocampus on the left side with the left dorsomedial prefrontal cortex seed region. This helps explain why there was no effect of the drug on the right connectivity between the hippocampus and the dorsomedial prefrontal cortex. Further studies are required to address whether connectivity on the right might be revealed with greater volunteer numbers or with reduced thresholding. Also further studies are required to address whether changes are also seen with antidepressant medication in other brain areas, such as the anterior cingulate and orbitofrontal cortex, with the use of different seed regions, and also to ascertain whether similar effects are seen in acutely depressed patients.
Areas such as the prefrontal cortices, which are involved in cognition, and limbic areas, such as the anterior insula and hippocampus, which are involved in emotional processing, are known to behave in a reciprocal relationship. 5 To date, functional neuroimaging studies have revealed dysfunction of this cortico-limbic relationship in depression. 6 Metaanalysis has allowed the emergence of neural models, suggesting areas such as the medial prefrontal cortex, which can integrate both the cognitive and emotional aspects of situations, to function as the principal mediator in this reciprocal cortico-limbic relation in depression. 6, 7 Thus, the prefrontal cortex appears as a key target for antidepressant drug action.
Connectivity between the prefrontal cortex and the hippocampus is also affected in depression. 1, 8 The frontal-cortical limbic networks of which the hippocampus is part 9, 10 have been shown to underlie the regulation of emotional behaviour, 11, 12 with the hippocampus specifically having a role in the dysfunctional cognitive impairments associated with depressive episodes. 13 The hippocampus has previously been shown to be modulated by chronic antidepressant drug action in animals, 14 and thus our results may indicate its importance for also the early effects of SSRIs on the emotional modulation of cognition. Such early effects have also been seen in healthy volunteers after 7 days SSRI treatment. 15 The results from this study show that an SSRI can decrease resting state functional connectivity between a part of the dorsal medial prefrontal cortex seed region and a part of the default mode network, the hippocampus, in healthy volunteers. These results help further our understanding of the mechanism of action of antidepressant medications on neural networks, in the absence of specific task-related activity, in the human brain. Our analysis supports the proposal of Sheline et al.
1 that antidepressant action in depressed patients may involve normalisation of elevated resting state functional connectivity between key elements of default resting state networks. for the placebo and citalopram groups, the group difference in connectivity with the seed region and a graph of the % BOLD signal change extracted from the cluster of significant difference between the groups (Hippocampus À36 À22 À18 P = 0.037, whole-brain FWE-corrected FSL (http://www.fmrib.ox.ac.uk/fsl)).
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